[Maximum tolerated dose of tegafur in rats]. 1984

R Hirayama, and S Hamada, and J Matsumura, and Y Takagi, and T Miyanaga, and N Aoki, and Y Mishima

Maximum Tolerated Dose of Tegafur was estimated by per-oral administration in male Donryu rats. Tegafur was administered for 24 weeks at respective doses of 90 mg, 120 mg and 150 mg/kg/day. Six of 10 (60%) died during the treatment in those groups administered with 120 mg and 150 mg/kg/day, respectively. The cause of death of these rats was severe pneumonia. All 10 of the group given 60 mg/kg/day survived until end of the administration and were sacrificed for histological examination of organs. These rats showed apparent suppression of body weight gain compared with controls (p less than 0.001). Slight inflammation of the lungs was observed in all rats, congestion of the liver and local degeneration and necrosis of the liver cells in a few rats and cellular degeneration of bone marrow in one rat. There was no remarkable change in the digestive tract, kidney, thymus or reproductive organs. Accordingly, the Maximum Tolerated Dose of Tegafur was determined to be 90 mg/kg/day.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug

Related Publications

R Hirayama, and S Hamada, and J Matsumura, and Y Takagi, and T Miyanaga, and N Aoki, and Y Mishima
October 2019, British journal of clinical pharmacology,
R Hirayama, and S Hamada, and J Matsumura, and Y Takagi, and T Miyanaga, and N Aoki, and Y Mishima
December 2000, Pediatric hematology and oncology,
R Hirayama, and S Hamada, and J Matsumura, and Y Takagi, and T Miyanaga, and N Aoki, and Y Mishima
February 2009, Aquatic toxicology (Amsterdam, Netherlands),
R Hirayama, and S Hamada, and J Matsumura, and Y Takagi, and T Miyanaga, and N Aoki, and Y Mishima
January 1975, Environmental quality and safety. Supplement,
R Hirayama, and S Hamada, and J Matsumura, and Y Takagi, and T Miyanaga, and N Aoki, and Y Mishima
January 1992, International journal of radiation oncology, biology, physics,
R Hirayama, and S Hamada, and J Matsumura, and Y Takagi, and T Miyanaga, and N Aoki, and Y Mishima
August 1991, International journal of radiation oncology, biology, physics,
R Hirayama, and S Hamada, and J Matsumura, and Y Takagi, and T Miyanaga, and N Aoki, and Y Mishima
January 2022, Journal of experimental pharmacology,
R Hirayama, and S Hamada, and J Matsumura, and Y Takagi, and T Miyanaga, and N Aoki, and Y Mishima
February 1990, Regulatory toxicology and pharmacology : RTP,
R Hirayama, and S Hamada, and J Matsumura, and Y Takagi, and T Miyanaga, and N Aoki, and Y Mishima
July 2003, Oncology (Williston Park, N.Y.),
R Hirayama, and S Hamada, and J Matsumura, and Y Takagi, and T Miyanaga, and N Aoki, and Y Mishima
October 2015, The Lancet. Oncology,
Copied contents to your clipboard!